Breadcrumb Home News AbbVie pays $65M for options on Yale Biotech Spinout EvolveImmune's T-cell engagers Source: Fierce Biotech | Date: 11/06/2024 AbbVie pays $65M for options on Yale Biotech Spinout EvolveImmune's T-cell engagers Image Click here to view the full article Startups & Spinouts Faculty
